Hormones

Testosterone Enanthate

Evidence: strong_human

Mechanism of Action

Testosterone enanthate is a long-acting esterified testosterone prodrug with a heptanoic acid ester at the 17-beta hydroxyl group, extending its half-life to approximately 4.5-5 days. Upon hydrolysis by tissue esterases, free testosterone activates nuclear androgen receptors, upregulating anabolic gene transcription including myostatin suppression and IGF-1 induction. It also modulates the hypothalamic-pituitary-gonadal (HPG) axis via negative feedback on GnRH and LH secretion.

Dosing Protocol

Standard: Research indicates 100-200 mg administered via intramuscular or subcutaneous injection every 7-14 days for testosterone replacement.

Maintenance: Research indicates 100-150 mg weekly or 50-75 mg twice weekly, titrated to trough levels of 500-900 ng/dL.

Administration: intramuscularsubcutaneous

Timing: Consistent injection schedule. Twice-weekly splits provide more stable blood levels due to the slightly shorter half-life compared to cypionate.

Duration: Ongoing for TRT. Suppression of endogenous production is expected within weeks of initiation.

Notes

Pharmacokinetically near-identical to testosterone cypionate with a marginally shorter half-life. Required bloodwork monitoring: Total testosterone (trough), free testosterone, estradiol (sensitive), CBC with hematocrit (every 3-6 months), PSA (baseline + annual for men >40), CMP, lipid panel. Enanthate produces a slightly higher Cmax than cypionate, which may cause more fluctuation in sensitive individuals. Subcutaneous injection has been validated as bioequivalent to IM with lower injection site pain. Medical supervision required.

Stacking

  • hCG (fertility preservation)
  • Anastrozole (estrogen management)
  • DHEA
  • Nandrolone (joint support)

Interactions

  • Anticoagulants (Warfarin) [HIGH] — Testosterone increases erythropoiesis; monitor INR and hematocrit closely.
  • Insulin / Oral hypoglycemics [MEDIUM] — Improved insulin sensitivity may require diabetes medication dose adjustment.
  • Corticosteroids [MEDIUM] — Additive fluid retention risk; monitor blood pressure and edema.

Contraindications

  • Prostate cancer or elevated PSA without urological clearance
  • Male breast cancer
  • Polycythemia (hematocrit >54%)
  • Untreated severe obstructive sleep apnea
  • Uncontrolled heart failure
  • Pregnancy or potential pregnancy exposure

Side Effects

  • Polycythemia / elevated hematocrit
  • Acne and oily skin
  • Testicular atrophy (without hCG)
  • Gynecomastia
  • Mood fluctuations
  • Fluid retention
  • Hair thinning (androgen-sensitive individuals)

Key Papers

  • 10.1210/jc.2018-01307
  • 10.1097/JU.0000000000002301
  • 10.1016/j.jsxm.2018.01.016

Source Quality

FDA-approved pharmaceutical product (Delatestryl). Also available from compounding pharmacies at 200-250 mg/mL. Interchangeable with cypionate at equivalent doses.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Testosterone Enanthate Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds